Their expression correlates with advanced stages of disease and poor prognosis (1, 3–5), and multiple lines of evidence implicate SSX proteins in processes of tumor cell dissemination, such as epithelial-to-mesenchymal transition (EMT) and loss of focal adhesion (6–8). The gene discussed is SSX2; the disease is neoplasm.